Dana (DAN) insider files Form 144 to sell 13,300 shares

Dana Inc. (DAN) has a planned sale of restricted stock reported on Form 144.

Rhea-AI Filing Summary

Dana Inc. (DAN) has a planned sale of restricted stock reported on Form 144. The person filing intends to sell 13,300 common shares through Fidelity Brokerage Services LLC, with an aggregate market value of $298,475.10, on or around 11/25/2025 on the NYSE. Shares outstanding are listed as 116,837,366.

The shares to be sold were acquired through multiple restricted stock vesting events from the issuer, treated as compensation. These vestings occurred on several dates between 02/10/2023 and 02/14/2024, with individual vested amounts such as 1,036, 4,210, 1,554, 1,710, 1,194, 2,207 and 1,389 common shares, all recorded as compensation.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Dana Inc. (DAN) disclose in this Form 144 filing?

The filing discloses a planned sale of 13,300 common shares of Dana Inc. stock by a holder, using Fidelity Brokerage Services LLC as broker, with an aggregate market value of $298,475.10 on or around 11/25/2025 on the NYSE.

How many Dana (DAN) shares are planned to be sold and what is their value?

The notice covers the planned sale of 13,300 common shares of Dana Inc., with an aggregate market value of $298,475.10 as indicated in the filing.

Where will the Dana Inc. (DAN) shares in this Form 144 be sold?

The shares are to be sold through Fidelity Brokerage Services LLC, with the securities exchange named as the NYSE and an approximate sale date of 11/25/2025.

How were the Dana (DAN) shares being sold under Form 144 acquired?

The common shares were acquired through multiple restricted stock vesting transactions from the issuer between 02/10/2023 and 02/14/2024, all identified as compensation.

How many Dana Inc. (DAN) shares are shown as outstanding in this Form 144?

The filing lists 116,837,366 common shares as the number of shares or other units outstanding for Dana Inc.

Does the Dana (DAN) Form 144 include any representation about undisclosed adverse information?

Yes. By signing, the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/25/2025 - 03:15 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002035862
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	DANA Inc
SEC File Number	001-01063
Address of Issuer	3939 TECHNOLOGY DRIVE MAUMEE OHIO 43537
Phone	419-887-3000
Name of Person for Whose Account the Securities are To Be Sold	Price Craig C
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	13300	298475.10	116837366	11/25/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/10/2023	Restricted Stock Vesting	Issuer			1036	02/10/2023	Compensation
Common	02/14/2023	Restricted Stock Vesting	Issuer			4210	02/14/2023	Compensation
Common	02/15/2023	Restricted Stock Vesting	Issuer			1554	02/15/2023	Compensation
Common	12/14/2023	Restricted Stock Vesting	Issuer			1710	12/14/2023	Compensation
Common	02/09/2024	Restricted Stock Vesting	Issuer			1194	02/09/2024	Compensation
Common	02/13/2024	Restricted Stock Vesting	Issuer			2207	02/13/2024	Compensation
Common	02/14/2024	Restricted Stock Vesting	Issuer			1389	02/14/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Michael C. Price and Craig C. Price are one and the same person.
Date of Notice	11/25/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gerardo Ibarra-Munoz, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Michael C. Price
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)